Active metalloproteases of the a disintegrin and metalloprotease (ADAM) family: Biological function and structure

Journal of Proteome Research

Volumn 10, Issue 1, 2011, Pages 17-33

  Klein, Theo ^a   Bischoff, Rainer ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adam 17; Function; Integrin; Metalloprotease; Proteolysis

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ENZYME ACTIVITY; ENZYME STRUCTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW;

ADAM PROTEINS; ANIMALS; HUMANS; MICE; PROTEIN CONFORMATION;

EID: 79951519159     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100556z     Document Type: Review

References (249)

1. Primakoff P. Hyatt H. Tredick-Kline J. Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion Journal of Cell Biology 1987: 104:1 141-149(Pubitemid 17018665)
2. Blobel, C. P.; Myles, D. G.; Primakoff, P.; White, J. M. Proteolytic processing of a protein involved in sperm-egg fusion correlates with acquisition of fertilization competence. J. Cell Biol. 1990, 111 (1), 69-78.
3. Blobel, C. P.; Wolfsberg, T. G.; Turck, C. W.; Myles, D. G.; Primakoff, P.; White, J. M. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 1992, 356 (6366), 248-52.
4. Wolfsberg, T. G.; Straight, P. D.; Gerena, R. L.; Huovila, A. P.; Primakoff, P.; Myles, D. G. White JM: ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 1995, 169 (1), 378-83.
5. Takeda, S.; Igarashi, T.; Mori, H.; Araki, S. Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J. 2006, 25 (11), 2388-96. (Pubitemid 44012222)
6. Eto, K.; Huet, C.; Tarui, T.; Kupriyanov, S.; Liu, H. Z.; Puzon- McLaughlin, W.; Zhang, X. P.; Sheppard, D.; Engvall, E.; Takada, Y. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for spermegg binding and other cell interactions. J. Biol. Chem. 2002, 277 (20), 17804-10. (Pubitemid 34967588)
7. Zhang, X. P.; Kamata, T.; Yokoyama, K.; Puzon-McLaughlin, W.; Takada, Y. Specific interaction of the recombinant disintegrinlike domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J. Biol. Chem. 1998, 273 (13), 7345-50. (Pubitemid 28152754)
8. Lu, D.; Chung, K. F.; Xia, M.; Lu, X.; Scully, M.; Kakkar, V. Integrin binding characteristics of the disintegrin-like domain of ADAM- 15. Thromb.Haemost. 2006, 96 (5), 642-51. (Pubitemid 44782545)
9. Lu, X.; Lu, D.; Scully, M. F.; Kakkar, V. V. Structure-activity relationship studies on ADAM protein-integrin interactions. Cardiovasc. Hematol. Agents Med. Chem. 2007, 5 (1), 29-42. (Pubitemid 46062420)
10. Chen, H.; Sampson, N. S. Mediation of sperm-egg fusion: evidence that mouse egg alpha6beta1 integrin is the receptor for sperm fertilinbeta. Chem. Biol. 1999, 6 (1), 1-10. (Pubitemid 29363040)
11. Rubinstein, E.; Ziyyat, A.; Wolf, J. P.; Le Naour, F.; Boucheix, C. The molecular players of sperm-egg fusion in mammals. Semin. Cell Dev. Biol. 2006, 17 (2), 254-63. (Pubitemid 44051942)
12. Jury, J. A.; Frayne, J.; Hall, L. The human fertilin alpha gene is non-functional: implications for its proposed role in fertilization. Biochem. J. 1997, 321 (Pt 3), 577-81. (Pubitemid 27084861)
13. Cho, C.; Bunch, D. O.; Faure, J. E.; Goulding, E. H.; Eddy, E. M.; Primakoff, P.; Myles, D. G. Fertilization defects in sperm from mice lacking fertilin beta. Science 1998, 281 (5384), 1857-9. (Pubitemid 28450507)
14. Tomczuk, M.; Takahashi, Y.; Huang, J.; Murase, S.; Mistretta, M.; Klaffky, E.; Sutherland, A.; Bolling, L.; Coonrod, S.; Marcinkiewicz, C.; Sheppard, D.; Stepp, M. A.; White, J. M. Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3. Exp. Cell Res. 2003, 290 (1), 68-81.
15. Iba, K.; Albrechtsen, R.; Gilpin, B.; Frohlich, C.; Loechel, F.; Zolkiewska, A.; Ishiguro, K.; Kojima, T.; Liu, W.; Langford, J. K.; Sanderson, R. D.; Brakebusch, C.; Fassler, R.; Wewer, U. M. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J. Cell Biol. 2000, 149 (5), 1143- 56.
16. Gaultier, A.; Cousin, H.; Darribere, T.; Alfandari, D. ADAM13 disintegrin and cysteine-rich domains bind to the second heparin- binding domain of fibronectin. J. Biol. Chem. 2002, 277 (26), 23336-44. (Pubitemid 34952164)
17. Blobel, C. P.; White, J. M. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr. Opin. Cell Biol. 1992, 4 (5), 760-5.
18. Kang, Q.; Cao, Y. Zolkiewska A: Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells. Biochem. J. 2000, 352 Pt 3, 883-92. (Pubitemid 32015046)
19. Galliano, M. F.; Huet, C.; Frygelius, J.; Polgren, A.; Wewer, U. M.; Engvall, E. Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion. J. Biol. Chem. 2000, 275 (18), 13933-9.
20. Izumi, Y.; Hirata, M.; Hasuwa, H.; Iwamoto, R.; Umata, T.; Miyado, K.; Tamai, Y.; Kurisaki, T.; Sehara-Fujisawa, A.; Ohno, S.; Mekada, E. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998, 17 (24), 7260-72.
21. Zhu, G. Z.; Lin, Y.; Myles, D. G.; Primakoff, P. Identification of four novel ADAMs with potential roles in spermatogenesis and fertilization. Gene 1999, 234 (2), 227-37.
22. Schlomann, U.; Wildeboer, D.; Webster, A.; Antropova, O.; Zeuschner, D.; Knight, C. G.; Docherty, A. J.; Lambert, M.; Skelton, L.; Jockusch, H.; Bartsch, J. W. The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J. Biol. Chem. 2002, 277 (50), 48210-9. (Pubitemid 35470772)
23. Howard, L.; Maciewicz, R. A.; Blobel, C. P. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem. J. 2000, 348 Pt 1, 21-7. (Pubitemid 30312126)
24. Milla, M. E.; Leesnitzer, M. A.; Moss, M. L.; Clay, W. C.; Carter, H. L.; Miller, A. B.; Su, J. L.; Lambert, M. H.; Willard, D. H.; Sheeley, D. M.; Kost, T. A.; Burkhart, W.; Moyer, M.; Blackburn, R. K.; Pahel, G. L.; Mitchell, J. L.; Hoffman, C. R.; Becherer, J. D. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J. Biol. Chem. 1999, 274 (43), 30563-70.
25. Anders, A.; Gilbert, S.; Garten, W.; Postina, R.; Fahrenholz, F. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 2001, 15 (10), 1837-9.
26. Black, R. A.; Rauch, C. T.; Kozlosky, C. J.; Peschon, J. J.; Slack, J. L.; Wolfson, M. F.; Castner, B. J.; Stocking, K. L.; Reddy, P.; Srinivasan, S.; Nelson, N.; Boiani, N.; Schooley, K. A.; Gerhart, M.; Davis, R.; Fitzner, J. N.; Johnson, R. S.; Paxton, R. J.; March, C. J.; Cerretti, D. P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385 (6618), 729-33. (Pubitemid 27098094)
27. Moss, M. L.; Jin, S. L.; Milla, M. E.; Bickett, D. M.; Burkhart, W.; Carter, H. L.; Chen, W. J.; Clay, W. C.; Didsbury, J. R.; Hassler, D.; Hoffman, C. R.; Kost, T. A.; Lambert, M. H.; Leesnitzer, M. A.; McCauley, P.; McGeehan, G.; Mitchell, J.; Moyer, M.; Pahel, G.; Rocque, W.; Overton, L. K.; Schoenen, F.; Seaton, T.; Su, J. L.; Becherer, J. D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997, 385 (6618), 733-6. (Pubitemid 27098095)
28. Yoshida, S.; Setoguchi, M.; Higuchi, Y.; Akizuki, S.; Yamamoto, S. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int. Immunol. 1990, 2 (6), 585-91. (Pubitemid 20218437)
29. Yoshiyama, K.; Higuchi, Y.; Kataoka, M.; Matsuura, K.; Yamamoto, S. CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics 1997, 41 (1), 56-62. (Pubitemid 27152821)
30. Kataoka, M.; Yoshiyama, K.; Matsuura, K.; Hijiya, N.; Higuchi, Y.; Yamamoto, S. Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location. J. Biol. Chem. 1997, 272 (29), 18209-15.
31. Hall, T.; Leone, J. W.; Wiese, J. F.; Griggs, D. W.; Pegg, L. E.; Pauley, A. M.; Tomasselli, A. G.; Zack, M. D. Autoactivation of human ADAM8: a novel pre-processing step is required for catalytic activity. Biosci. Rep. 2009, 29 (4), 217-28.
32. Choi, S. J.; Han, J. H.; Roodman, G. D. ADAM8: a novel osteoclast stimulating factor. J. Bone Miner. Res. 2001, 16 (5), 814-22. (Pubitemid 32332291)
33. Amour, A.; Knight, C. G.; English, W. R.; Webster, A.; Slocombe, P. M.; Knauper, V.; Docherty, A. J.; Becherer, J. D.; Blobel, C. P.; Murphy, G. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett. 2002, 524 (1-3), 154-8. (Pubitemid 34804852)
34. Schlomann, U.; Rathke-Hartlieb, S.; Yamamoto, S.; Jockusch, H.; Bartsch, J. W. Tumor necrosis factor alpha induces a metalloprotease- disintegrin, ADAM8 (CD 156): implications for neuronglia interactions during neurodegeneration. J. Neurosci. 2000, 20 (21), 7964-71.
35. Sriraman, V.; Eichenlaub-Ritter, U.; Bartsch, J. W.; Rittger, A.; Mulders, S. M.; Richards, J. S. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors. Biol. Reprod. 2008, 78 (6), 1038-48. (Pubitemid 351749296)
36. Naus, S.; Reipschlager, S.; Wildeboer, D.; Lichtenthaler, S. F.; Mitterreiter, S.; Guan, Z.; Moss, M. L.; Bartsch, J. W. Identification of candidate substrates for ectodomain shedding by the metalloprotease- disintegrin ADAM8. Biol. Chem. 2006, 387 (3), 337-46.
37. Naus, S.; Richter, M.; Wildeboer, D.; Moss, M.; Schachner, M.; Bartsch, J. W. Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. J. Biol. Chem. 2004, 279 (16), 16083-90. (Pubitemid 38509299)
38. Kelly, K.; Hutchinson, G.; Nebenius-Oosthuizen, D.; Smith, A. J.; Bartsch, J. W.; Horiuchi, K.; Rittger, A.; Manova, K.; Docherty, A. J.; Blobel, C. P. Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev. Dyn. 2005, 232 (1), 221-31. (Pubitemid 40070875)
39. King, N. E.; Zimmermann, N.; Pope, S. M.; Fulkerson, P. C.; Nikolaidis, N. M.; Mishra, A.; Witte, D. P.; Rothenberg, M. E. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am. J. Respir. Cell Mol. Biol. 2004, 31 (3), 257-65. (Pubitemid 39180294)
40. Chiba, Y.; Onoda, S.; Hattori, Y.; Maitani, Y.; Sakai, H.; Misawa, M. Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma. Lung 2009, 187 (3), 179-85.
41. Naus, S.; Blanchet, M. R.; Gossens, K.; Zaph, C.; Bartsch, J. W.; McNagny, K. M.; Ziltener, H. J. The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma. Am. J. Respir. Crit. Care Med. 2010, 181 (12), 1318-1328.
42. Higuchi, Y.; Yasui, A.; Matsuura, K.; Yamamoto, S. CD156 transgenic mice. Different responses between inflammatory types. Pathobiology 2002, 70 (1), 47-54. (Pubitemid 36151553)
43. Matsuno, O.; Miyazaki, E.; Nureki, S.; Ueno, T.; Kumamoto, T.; Higuchi, Y. Role of ADAM8 in experimental asthma. Immunol. Lett. 2006, 102 (1), 67-73. (Pubitemid 41606041)
44. Matsuno, O.; Miyazaki, E.; Nureki, S.; Ueno, T.; Ando, M.; Ito, K.; Kumamoto, T.; Higuchi, Y. Elevated soluble ADAM8 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia. Int. Arch. Allergy Immunol. 2007, 142 (4), 285-90. (Pubitemid 46425808)
45. Foley, S. C.; Mogas, A. K.; Olivenstein, R.; Fiset, P. O.; Chakir, J.; Bourbeau, J.; Ernst, P.; Lemiere, C.; Martin, J. G.; Hamid, Q. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J. Allergy Clin. Immunol. 2007, 119 (4), 863-71. (Pubitemid 46527832)
46. Gomez-Gaviro, M.; Dominguez-Luis, M.; Canchado, J.; Calafat, J.; Janssen, H.; Lara-Pezzi, E.; Fourie, A.; Tugores, A.; Valenzuela- Fernandez, A.; Mollinedo, F.; Sanchez-Madrid, F.; Diaz-Gonzalez, F. Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J. Immunol. 2007, 178 (12), 8053-63. (Pubitemid 46898077)
47. Zack, M. D.; Melton, M. A.; Stock, J. L.; Storer, C. E.; Barve, R. A.; Minnerly, J. C.; Weiss, D. J.; Stejskal, J. A.; Tortorella, M. D.; Turk, J. R.; Shevlin, K. M.; Malfait, A. M. Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8). Clin. Exp. Immunol. 2009, 158 (2), 246-56.
48. Ainola, M.; Li, T. F.; Mandelin, J.; Hukkanen, M.; Choi, S. J.; Salo, J.; Konttinen, Y. T. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction. Ann. Rheum. Dis. 2009, 68 (3), 427-434.
49. Mandelin, J.; Li, T. F.; Hukkanen, M. V.; Liljestrom, M.; Chen, Z. K.; Santavirta, S.; Kitti, U.; Konttinen, Y. T. Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J. Rheumatol. 2003, 30 (9), 2033-8. (Pubitemid 37075558)
50. Valkovskaya, N.; Kayed, H.; Felix, K.; Hartmann, D.; Giese, N. A.; Osinsky, S. P.; Friess, H.; Kleeff, J. ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J. Cell Mol. Med. 2007, 11 (5), 1162-74. (Pubitemid 350037057)
51. Valkovskaya, N. V. Hypoxia-dependent expression of ADAM8 in human pancreatic cancer cell lines. Exp. Oncol. 2008, 30 (2), 129-32. (Pubitemid 351951389)
52. Wildeboer, D.; Naus, S.; Amy Sang, Q. X.; Bartsch, J. W.; Pagenstecher, A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J. Neuropathol. Exp. Neurol. 2006, 65 (5), 516-27. (Pubitemid 44297273)
53. Hernandez, I.; Moreno, J. L.; Zandueta, C.; Montuenga, L.; Lecanda, F. Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer. Oncogene 2010, 29 (26), 3758-3769.
54. Ishikawa, N.; Daigo, Y.; Yasui, W.; Inai, K.; Nishimura, H.; Tsuchiya, E.; Kohno, N.; Nakamura, Y. ADAM8 as a novel serological and histochemical marker for lung cancer. Clin. Cancer Res. 2004, 10 (24), 8363-70. (Pubitemid 40053398)
55. Fritzsche, F. R.; Jung, M.; Xu, C.; Rabien, A.; Schicktanz, H.; Stephan, C.; Dietel, M.; Jung, K.; Kristiansen, G. ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis. Virchows Arch. 2006, 449 (6), 628-36. (Pubitemid 44832633)
56. Roemer, A.; Schwettmann, L.; Jung, M.; Stephan, C.; Roigas, J.; Kristiansen, G.; Loening, S. A.; Lichtinghagen, R.; Jung, K. The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers. J. Urol. 2004, 172 (6 Pt 1), 2162-6. (Pubitemid 39507483)
57. Roemer, A.; Schwettmann, L.; Jung, M.; Roigas, J.; Kristiansen, G.; Schnorr, D.; Loening, S. A.; Jung, K.; Lichtinghagen, R. Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome. Oncol. Rep. 2004, 11 (2), 529-36.
58. Weskamp, G.; Kratzschmar, J.; Reid, M. S.; Blobel, C. P. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell Biol. 1996, 132 (4), 717-26. (Pubitemid 26069249)
59. McKie, N.; Dallas, D. J.; Edwards, T.; Apperley, J. F.; Russell, R. G. Croucher PI: Cloning of a novel membrane-linked metalloproteinase from human myeloma cells. Biochem. J. 1996, 318 (Pt 2), 459-62. (Pubitemid 26305944)
60. Roghani, M.; Becherer, J. D.; Moss, M. L.; Atherton, R. E.; Erdjument-Bromage, H.; Arribas, J.; Blackburn, R. K.; Weskamp, G.; Tempst, P.; Blobel, C. P. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 1999, 274 (6), 3531-40. (Pubitemid 29077194)
61. Schwettmann, L.; Tschesche, H. Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. Protein Expr. Purif. 2001, 21 (1), 65-70. (Pubitemid 32614497)
62. Weskamp, G.; Cai, H.; Brodie, T. A.; Higashyama, S.; Manova, K.; Ludwig, T.; Blobel, C. P. Mice lacking the metalloproteasedisintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 2002, 22 (5), 1537-44. (Pubitemid 34150789)
63. Parry, D. A.; Toomes, C.; Bida, L.; Danciger, M.; Towns, K. V.; McKibbin, M.; Jacobson, S. G.; Logan, C. V.; Ali, M.; Bond, J.; Chance, R.; Swendeman, S.; Daniele, L. L.; Springell, K.; Adams, M.; Johnson, C. A.; Booth, A. P.; Jafri, H.; Rashid, Y.; Banin, E.; Strom, T. M.; Farber, D. B.; Sharon, D.; Blobel, C. P.; Pugh, E. N., Jr.; Pierce, E. A.; Inglehearn, C. F. Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice. Am. J. Hum. Genet. 2009, 84 (5), 683-91.
64. Asai, M.; Hattori, C.; Szabo, B.; Sasagawa, N.; Maruyama, K.; Tanuma, S.; Ishiura, S. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem. Biophys. Res. Commun. 2003, 301 (1), 231-5. (Pubitemid 36268873)
65. Mahimkar, R. M.; Baricos, W. H.; Visaya, O.; Pollock, A. S.; Lovett, D. H. Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney. J. Am. Soc. Nephrol. 2000, 11 (4), 595-603. (Pubitemid 30171868)
66. Mahimkar, R. M.; Visaya, O.; Pollock, A. S.; Lovett, D. H. The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins. Biochem. J. 2005, 385 (Pt 2), 461-8. (Pubitemid 40165079)
67. Mazzocca, A.; Coppari, R.; De Franco, R.; Cho, J. Y.; Libermann, T. A.; Pinzani, M.; Toker, A. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 2005, 65 (11), 4728-38. (Pubitemid 40740809)
68. Shigemura, K.; Sung, S. Y.; Kubo, H.; Arnold, R. S.; Fujisawa, M.; Gotoh, A.; Zhau, H. E.; Chung, L. W. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Prostate 2007, 67 (7), 722-31. (Pubitemid 46709441)
69. Sung, S. Y.; Kubo, H.; Shigemura, K.; Arnold, R. S.; Logani, S.; Wang, R.; Konaka, H.; Nakagawa, M.; Mousses, S.; Amin, M.; Anderson, C.; Johnstone, P.; Petros, J. A.; Marshall, F. F.; Zhau, H. E.; Chung, L. W. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res. 2006, 66 (19), 9519-26. (Pubitemid 44623650)
70. Fritzsche, F. R.; Jung, M.; Tolle, A.; Wild, P.; Hartmann, A.; Wassermann, K.; Rabien, A.; Lein, M.; Dietel, M.; Pilarsky, C.; Calvano, D.; Grutzmann, R.; Jung, K.; Kristiansen, G. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur. Urol. 2008, 54 (5), 1097-1106.
71. Fritzsche, F. R.; Wassermann, K.; Jung, M.; Tolle, A.; Kristiansen, I.; Lein, M.; Johannsen, M.; Dietel, M.; Jung, K.; Kristiansen, G. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 2008, 8, 179.
72. Fahrenholz, F.; Postina, R. Alpha-secretase activation-an approach to Alzheimer's disease therapy. Neurodegener. Dis. 2006, 3 (4-5), 255-61. (Pubitemid 44600312)
73. Deuss, M.; Reiss, K.; Hartmann, D. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr. Alzheimer Res. 2008, 5 (2), 187-201. (Pubitemid 351536344)
74. Postina, R. A closer look at alpha-secretase. Curr. Alzheimer Res. 2008, 5 (2), 179-86.
75. Cong, L.; Jia, J. Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease. Neurobiol. Aging, doi: 10.1016/j.neurobiolaging.2009.01.001.
76. Howard, L.; Glynn, P. Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation. Methods Enzymol. 1995, 248, 388-95.
77. Howard, L.; Lu, X.; Mitchell, S.; Griffiths, S.; Glynn, P. Molecular cloning of MADM: a catalytically active mammalian disintegrinmetalloprotease expressed in various cell types. Biochem. J. 1996, 317 (Pt 1), 45-50. (Pubitemid 26238327)
78. Rooke, J.; Pan, D.; Xu, T. Rubin GM: KUZ, a conserved metalloprotease- disintegrin protein with two roles in Drosophila neurogenesis. Science 1996, 273 (5279), 1227-31. (Pubitemid 26293213)
79. Dallas, D. J.; Genever, P. G.; Patton, A. J.; Millichip, M. I.; McKie, N.; Skerry, T. M. Localization of ADAM10 and Notch receptors in bone. Bone 1999, 25 (1), 9-15. (Pubitemid 29322055)
80. Moss, M. L.; Bomar, M.; Liu, Q.; Sage, H.; Dempsey, P.; Lenhart, P. M.; Gillispie, P. A.; Stoeck, A.; Wildeboer, D.; Bartsch, J. W.; Palmisano, R.; Zhou, P. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 2007, 282 (49), 35712-21. (Pubitemid 350277116)
81. Rapti, M.; Atkinson, S. J.; Lee, M. H.; Trim, A.; Moss, M.; Murphy, G. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Biochem. J. 2008, 411 (2), 433-9. (Pubitemid 351580196)
82. Millichip, M. I.; Dallas, D. J.; Wu, E.; Dale, S.; McKie, N. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Commun. 1998, 245 (2), 594-8. (Pubitemid 28418550)
83. Sahin, U.; Weskamp, G.; Kelly, K.; Zhou, H. M.; Higashiyama, S.; Peschon, J.; Hartmann, D.; Saftig, P.; Blobel, C. P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 2004, 164 (5), 769-79. (Pubitemid 38282960)
84. Janes, P. W.; Saha, N.; Barton, W. A.; Kolev, M. V.; Wimmer- Kleikamp, S. H.; Nievergall, E.; Blobel, C. P.; Himanen, J. P.; Lackmann, M.; Nikolov, D. B. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005, 123 (2), 291-304. (Pubitemid 41457218)
85. Vincent, B.; Paitel, E.; Saftig, P.; Frobert, Y.; Hartmann, D.; De Strooper, B.; Grassi, J.; Lopez-Perez, E.; Checler, F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 2001, 276 (41), 37743-6.
86. Abel, S.; Hundhausen, C.; Mentlein, R.; Schulte, A.; Berkhout, T. A.; Broadway, N.; Hartmann, D.; Sedlacek, R.; Dietrich, S.; Muetze, B.; Schuster, B.; Kallen, K. J.; Saftig, P.; Rose-John, S.; Ludwig, A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 2004, 172 (10), 6362-72. (Pubitemid 38621245)
87. Hundhausen, C.; Misztela, D.; Berkhout, T. A.; Broadway, N.; Saftig, P.; Reiss, K.; Hartmann, D.; Fahrenholz, F.; Postina, R.; Matthews, V.; Kallen, K. J.; Rose-John, S.; Ludwig, A. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1- mediated cell-cell adhesion. Blood 2003, 102 (4), 1186-95. (Pubitemid 36988021)
88. Gutwein, P.; Mechtersheimer, S.; Riedle, S.; Stoeck, A.; Gast, D.; Joumaa, S.; Zentgraf, H.; Fogel, M.; Altevogt, D. P. ADAM10- mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J. 2003, 17 (2), 292-4.
89. Ludwig, A.; Hundhausen, C.; Lambert, M. H.; Broadway, N.; Andrews, R. C.; Bickett, D. M.; Leesnitzer, M. A.; Becherer, J. D. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb. Chem. High Throughput. Screen. 2005, 8 (2), 161-71. (Pubitemid 40388743)
90. Zheng, Y.; Saftig, P.; Hartmann, D.; Blobel, C. Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J. Biol. Chem. 2004, 279 (41), 42898-906. (Pubitemid 39372180)
91. Louvi, A.; Artavanis-Tsakonas, S. Notch signalling in vertebrate neural development. Nat. Rev. Neurosci. 2006, 7 (2), 93-102. (Pubitemid 43151596)
92. Sotillos, S.; Roch, F.; Campuzano, S. The metalloproteasedisintegrin Kuzbanian participates in Notch activation during growth and patterning of Drosophila imaginal discs. Development 1997, 124 (23), 4769-79. (Pubitemid 28014380)
93. Wen, C.; Metzstein, M. M.; Greenwald, I. SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. Development 1997, 124 (23), 4759-67. (Pubitemid 28014379)
94. Brou, C.; Logeat, F.; Gupta, N.; Bessia, C.; LeBail, O.; Doedens, J. R.; Cumano, A.; Roux, P.; Black, R. A.; Israel, A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 2000, 5 (2), 207-16. (Pubitemid 30628080)
95. Hartmann, D.; De Strooper, B.; Serneels, L.; Craessaerts, K.; Herreman, A.; Annaert, W.; Umans, L.; Lubke, T.; Lena, I. A.; von Figura, K.; Saftig, P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 2002, 11 (21), 2615-24. (Pubitemid 35174691)
96. Krebs, L. T.; Xue, Y.; Norton, C. R.; Shutter, J. R.; Maguire, M.; Sundberg, J. P.; Gallahan, D.; Closson, V.; Kitajewski, J.; Callahan, R.; Smith, G. H.; Stark, K. L.; Gridley, T. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14 (11), 1343-52. (Pubitemid 30397078)
97. Jorissen, E.; Prox, J.; Bernreuther, C.; Weber, S.; Schwanbeck, R.; Serneels, L.; Snellinx, A.; Craessaerts, K.; Thathiah, A.; Tesseur, I.; Bartsch, U.; Weskamp, G.; Blobel, C. P.; Glatzel, M.; De Strooper, B.; Saftig, P. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 2010, 30 (14), 4833-44.
98. Karkkainen, I.; Rybnikova, E.; Pelto-Huikko, M.; Huovila, A. P. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell Neurosci. 2000, 15 (6), 547-60. (Pubitemid 30436928)
99. Lammich, S.; Kojro, E.; Postina, R.; Gilbert, S.; Pfeiffer, R.; Jasionowski, M.; Haass, C.; Fahrenholz, F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (7), 3922-7. (Pubitemid 29169012)
100. Schroeder, A.; Fahrenholz, F.; Schmitt, U. Effect of a dominantnegative form of ADAM10 in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 2009, 16 (2), 309-14.
101. Gavert, N.; Sheffer, M.; Raveh, S.; Spaderna, S.; Shtutman, M.; Brabletz, T.; Barany, F.; Paty, P.; Notterman, D.; Domany, E.; Ben Ze'ev, A. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 2007, 67 (16), 7703-12. (Pubitemid 47281363)
102. Nagano, O.; Murakami, D.; Hartmann, D.; De Strooper, B.; Saftig, P.; Iwatsubo, T.; Nakajima, M.; Shinohara, M.; Saya, H. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J. Cell Biol. 2004, 165 (6), 893-902. (Pubitemid 38821979)
103. Lee, S. B.; Schramme, A.; Doberstein, K.; Dummer, R.; Abdel- Bakky, M. S.; Keller, S.; Altevogt, P.; Oh, S. T.; Reichrath, J.; Oxmann, D.; Pfeilschifter, J.; Mihic-Probst, D.; Gutwein, P. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J. Invest. Dermatol. 2010, 130 (3), 763-73.
104. Liu, P. C.; Liu, X.; Li, Y.; Covington, M.; Wynn, R.; Huber, R.; Hillman, M.; Yang, G.; Ellis, D.; Marando, C.; Katiyar, K.; Bradley, J.; Abremski, K.; Stow, M.; Rupar, M.; Zhuo, J.; Li, Y. L.; Lin, Q.; Burns, D.; Xu, M.; Zhang, C.; Qian, D. Q.; He, C.; Sharief, V.; Weng, L.; Agrios, C.; Shi, E.; Metcalf, B.; Newton, R.; Friedman, S.; Yao, W.; Scherle, P.; Hollis, G.; Burn, T. C. Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol. Ther. 2006, 5 (6), 657-64. (Pubitemid 44024721)
105. Kohga, K.; Takehara, T.; Tatsumi, T.; Miyagi, T.; Ishida, H.; Ohkawa, K.; Kanto, T.; Hiramatsu, N.; Hayashi, N. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res. 2009, 69 (20), 8050-7.
106. Raucci, A.; Cugusi, S.; Antonelli, A.; Barabino, S. M.; Monti, L.; Bierhaus, A.; Reiss, K.; Saftig, P.; Bianchi, M. E. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008, 22 (10), 3716-3727.
107. Lemieux, G. A.; Blumenkron, F.; Yeung, N.; Zhou, P.; Williams, J.; Grammer, A. C.; Petrovich, R.; Lipsky, P. E.; Moss, M. L.; Werb, Z. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 2007, 282 (20), 14836-44. (Pubitemid 47093331)
108. Tanaka, M.; Itai, T.; Adachi, M.; Nagata, S. Downregulation of Fas ligand by shedding. Nat. Med. 1998, 4 (1), 31-6. (Pubitemid 28133076)
109. Schulte, M.; Reiss, K.; Lettau, M.; Maretzky, T.; Ludwig, A.; Hartmann, D.; De Strooper, B.; Janssen, O.; Saftig, P. ADAM10 regulates FasL cell surface expression and modulates FasLinduced cytotoxicity and activation-induced cell death. Cell Death Differ. 2007, 14 (5), 1040-9. (Pubitemid 46629842)
110. Yagami-Hiromasa, T.; Sato, T.; Kurisaki, T.; Kamijo, K.; Nabeshima, Y.; Fujisawa-Sehara, A. A metalloprotease-disintegrin participating in myoblast fusion. Nature 1995, 377 (6550), 652-6.
111. Gilpin, B. J.; Loechel, F.; Mattei, M. G.; Engvall, E.; Albrechtsen, R.; Wewer, U. M. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J. Biol. Chem. 1998, 273 (1), 157-66. (Pubitemid 28042189)
112. Loechel, F.; Gilpin, B. J.; Engvall, E.; Albrechtsen, R.; Wewer, U. M. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J. Biol. Chem. 1998, 273 (27), 16993-7. (Pubitemid 28311732)
113. Wewer, U. M.; Morgelin, M.; Holck, P.; Jacobsen, J.; Lydolph, M. C.; Johnsen, A. H.; Kveiborg, M.; Albrechtsen, R. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme. J. Biol. Chem. 2006, 281 (14), 9418-22. (Pubitemid 43864658)
114. Le Pabic, H.; Bonnier, D.; Wewer, U. M.; Coutand, A.; Musso, O.; Baffet, G.; Clement, B.; Theret, N. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 2003, 37 (5), 1056-66. (Pubitemid 36538682)
115. Le Pabic, H.; L'helgoualc'h, A.; Coutant, A.; Wewer, U. M.; Baffet, G.; Clement, B.; Theret, N. Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells. J. Hepatol. 2005, 43 (6), 1038-44. (Pubitemid 41627990)
116. Lafuste, P.; Sonnet, C.; Chazaud, B.; Dreyfus, P. A.; Gherardi, R. K.; Wewer, U. M.; Authier, F. J. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol. Biol. Cell 2005, 16 (2), 861-70. (Pubitemid 40165577)
117. Kawaguchi, N.; Sundberg, C.; Kveiborg, M.; Moghadaszadeh, B.; Asmar, M.; Dietrich, N.; Thodeti, C. K.; Nielsen, F. C.; Moller, P.; Mercurio, A. M.; Albrechtsen, R.; Wewer, U. M. ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. J. Cell Sci. 2003, 116 (Pt 19), 3893-904. (Pubitemid 37279305)
118. Kurisaki, T.; Masuda, A.; Sudo, K.; Sakagami, J.; Higashiyama, S.; Matsuda, Y.; Nagabukuro, A.; Tsuji, A.; Nabeshima, Y.; Asano, M.; Iwakura, Y.; Sehara-Fujisawa, A. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol. Cell. Biol. 2003, 23 (1), 55-61. (Pubitemid 36008500)
119. Kronqvist, P.; Kawaguchi, N.; Albrechtsen, R.; Xu, X.; Schroder, H. D.; Moghadaszadeh, B.; Nielsen, F. C.; Frohlich, C.; Engvall, E.; Wewer, U. M. ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. Am. J. Pathol. 2002, 161 (5), 1535-40. (Pubitemid 35265513)
120. Masaki, M.; Kurisaki, T.; Shirakawa, K.; Sehara-Fujisawa, A. Role of meltrin {alpha} (ADAM12) in obesity induced by high-fat diet. Endocrinology 2005, 146 (4), 1752-63. (Pubitemid 40396884)
121. Roy, R.; Wewer, U. M.; Zurakowski, D.; Pories, S. E.; Moses, M. A. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J. Biol. Chem. 2004, 279 (49), 51323-30. (Pubitemid 40017878)
122. Jacobsen, J.; Visse, R.; Sorensen, H. P.; Enghild, J. J.; Brew, K.; Wewer, U. M.; Nagase, H. Catalytic properties of ADAM12 and its domain deletion mutants. Biochemistry 2008, 47 (2), 537-47. (Pubitemid 351195426)
123. Loechel, F.; Fox, J. W.; Murphy, G.; Albrechtsen, R.; Wewer, U. M. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem. Biophys. Res. Commun. 2000, 278 (3), 511-5.
124. Asakura, M.; Kitakaze, M.; Takashima, S.; Liao, Y.; Ishikura, F.; Yoshinaka, T.; Ohmoto, H.; Node, K.; Yoshino, K.; Ishiguro, H.; Asanuma, H.; Sanada, S.; Matsumura, Y.; Takeda, H.; Beppu, S.; Tada, M.; Hori, M.; Higashiyama, S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8 (1), 35-40. (Pubitemid 34101726)
125. Ito, N.; Nomura, S.; Iwase, A.; Ito, T.; Kikkawa, F.; Tsujimoto, M.; Ishiura, S.; Mizutani, S. ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem. Biophys. Res. Commun. 2004, 314 (4), 1008-13. (Pubitemid 38142384)
126. Horiuchi, K.; Le Gall, S.; Schulte, M.; Yamaguchi, T.; Reiss, K.; Murphy, G.; Toyama, Y.; Hartmann, D.; Saftig, P.; Blobel, C. P. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 2007, 18 (1), 176-88. (Pubitemid 46066719)
127. Dyczynska, E.; Sun, D.; Yi, H.; Sehara-Fujisawa, A.; Blobel, C. P.; Zolkiewska, A. Proteolytic processing of delta-like 1 by ADAM proteases. J. Biol. Chem. 2007, 282 (1), 436-44. (Pubitemid 47076599)
128. Laigaard, J.; Spencer, K.; Christiansen, M.; Cowans, N. J.; Larsen, S. O.; Pedersen, B. N.; Wewer, U. M. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat. Diagn. 2006, 26 (10), 973-9. (Pubitemid 44671051)
129. Valinen, Y.; Peuhkurinen, S.; Jarvela, I. Y.; Laitinen, P.; Ryynanen, M. Maternal Serum ADAM12 Levels Correlate with PAPP-A Levels during the First Trimester. Gynecol. Obstet. Invest. 2010, 70 (1), 60-3.
130. Poon, L. C.; Chelemen, T.; Minekawa, R.; Frisova, V.; Nicolaides, K. H. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. Am. J. Obstet. Gynecol. 2009, 200 (5), 508-6.
131. Jorgensen, L. H.; Jensen, C. H.; Wewer, U. M.; Schroder, H. D. Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice. Am. J. Pathol. 2007, 171 (5), 1599-607. (Pubitemid 350158320)
132. Fedak, P. W.; Moravec, C. S.; McCarthy, P. M.; Altamentova, S. M.; Wong, A. P.; Skrtic, M.; Verma, S.; Weisel, R. D.; Li, R. K. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation 2006, 113 (2), 238-45.
133. Valdes, A. M.; Hart, D. J.; Jones, K. A.; Surdulescu, G.; Swarbrick, P.; Doyle, D. V.; Schafer, A. J.; Spector, T. D. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum. 2004, 50 (8), 2497-507. (Pubitemid 39062710)
134. Wewer, U. M.; Engvall, E.; Albrechtsen, R. ADAM12: The long and the short of it, The ADAM family of proteases, proteases in biology and disease; Hooper, N. M., Lendeckel, U., Eds.; Springer: The Netherlands, 2005; pp 123-46.
135. Iba, K.; Albrechtsen, R.; Gilpin, B. J.; Loechel, F.; Wewer, U. M. Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am. J. Pathol. 1999, 154 (5), 1489-501. (Pubitemid 29226444)
136. Peduto, L.; Reuter, V. E.; Sehara-Fujisawa, A.; Shaffer, D. R.; Scher, H. I.; Blobel, C. P. ADAM12 is highly expressed in carcinomaassociated stroma and is required for mouse prostate tumor progression. Oncogene 2006, 25 (39), 5462-6. (Pubitemid 44330288)
137. Carl-McGrath, S.; Lendeckel, U.; Ebert, M.; Roessner, A.; Rocken, C. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int. J. Oncol. 2005, 26 (1), 17-24.
138. Lendeckel, U.; Kohl, J.; Arndt, M.; Carl-McGrath, S.; Donat, H.; Rocken, C. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J. Cancer Res. Clin. Oncol. 2005, 131 (1), 41-8.
139. Kveiborg, M.; Frohlich, C.; Albrechtsen, R.; Tischler, V.; Dietrich, N.; Holck, P.; Kronqvist, P.; Rank, F.; Mercurio, A. M.; Wewer, U. M. A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res. 2005, 65 (11), 4754-61. (Pubitemid 40740812)
140. Sjoblom, T.; Jones, S.; Wood, L. D.; Parsons, D. W.; Lin, J.; Barber, T. D.; Mandelker, D.; Leary, R. J.; Ptak, J.; Silliman, N.; Szabo, S.; Buckhaults, P.; Farrell, C.; Meeh, P.; Markowitz, S. D.; Willis, J.; Dawson, D.; Willson, J. K.; Gazdar, A. F.; Hartigan, J.; Wu, L.; Liu, C.; Parmigiani, G.; Park, B. H.; Bachman, K. E.; Papadopoulos, N.; Vogelstein, B.; Kinzler, K. W.; Velculescu, V. E. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314 (5797), 268-74. (Pubitemid 44571966)
141. Frohlich, C.; Albrechtsen, R.; Dyrskjot, L.; Rudkjaer, L.; Orntoft, T. F.; Wewer, U. M. Molecular profiling of ADAM12 in human bladder cancer. Clin. Cancer Res. 2006, 12 (24), 7359-68. (Pubitemid 46095409)
142. Kveiborg, M.; Albrechtsen, R.; Couchman, J. R.; Wewer, U. M. Cellular roles of ADAM12 in health and disease. Int. J. Biochem. Cell Biol. 2008, 40 (9), 1685-702.
143. Kratzschmar, J.; Lum, L.; Blobel, C. P. Metargidin, a membraneanchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J. Biol. Chem. 1996, 271 (9), 4593-6.
144. Horiuchi, K.; Weskamp, G.; Lum, L.; Hammes, H. P.; Cai, H.; Brodie, T. A.; Ludwig, T.; Chiusaroli, R.; Baron, R.; Preissner, K. T.; Manova, K.; Blobel, C. P. Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 2003, 23 (16), 5614-24. (Pubitemid 36951327)
145. Eto, K.; Puzon-McLaughlin, W.; Sheppard, D.; Sehara-Fujisawa, A.; Zhang, X. P.; Takada, Y. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and-15 disintegrin domains mediates cell-cell interaction. J. Biol. Chem. 2000, 275 (45), 34922-30.
146. Nath, D.; Slocombe, P. M.; Stephens, P. E.; Warn, A. Hutchinson GR, Yamada KM, Docherty AJ, Murphy G: Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells. J. Cell Sci. 1999, 112 (Pt 4), 579-87. (Pubitemid 29106204)
147. Herren, B.; Garton, K. J.; Coats, S.; Bowen-Pope, D. F.; Ross, R.; Raines, E. W. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions. Exp. Cell Res. 2001, 271 (1), 152-60. (Pubitemid 33071002)
148. Charrier, L.; Yan, Y.; Driss, A.; Laboisse, C. L.; Sitaraman, S. V.; Merlin, D. ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288 (2), G346-53.
149. Wu, J.; Zhang, L.; Ma, X.; Zhang, X.; Jin, J. Screening cellular proteins involved in the anti-proliferative effect of the ADAM15 disintegrin domain in murine melanoma cells. Oncol. Rep. 2008, 20 (3), 669-75.
150. Bohm, B. B.; Aigner, T.; Roy, B.; Brodie, T. A.; Blobel, C. P.; Burkhardt, H. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Arthritis Rheum. 2005, 52 (4), 1100-9.
151. Lu, D.; Xie, S.; Sukkar, M. B.; Lu, X.; Scully, M. F.; Chung, K. F. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15. Am. J. Respir. Cell Mol. Biol. 2007, 37 (4), 494-500. (Pubitemid 47502725)
152. Mosnier, J. F.; Jarry, A.; Bou-Hanna, C.; Denis, M. G.; Merlin, D.; Laboisse, C. L. ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease. Lab. Invest. 2006, 86 (10), 1064-73. (Pubitemid 44423070)
153. Langer, H.; May, A. E.; Bultmann, A.; Gawaz, M. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation. Thromb. Haemost. 2005, 94 (3), 555-61. (Pubitemid 41300852)
154. Al Fakhri, N.; Wilhelm, J.; Hahn, M.; Heidt, M.; Hehrlein, F. W.; Endisch, A. M.; Hupp, T.; Cherian, S. M.; Bobryshev, Y. V.; Lord, R. S.; Katz, N. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis. J. Cell Biochem. 2003, 89 (4), 808-23. (Pubitemid 36759140)
155. Martin, J.; Eynstone, L. V.; Davies, M.; Williams, J. D.; Steadman, R. The role of ADAM 15 in glomerular mesangial cell migration. J. Biol. Chem. 2002, 277 (37), 33683-9.
156. Fourie, A. M.; Coles, F.; Moreno, V.; Karlsson, L. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 2003, 278 (33), 30469-77. (Pubitemid 36994550)
157. Najy, A. J.; Day, K. C.; Day, M. L. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J. Biol. Chem. 2008, 283 (26), 18393-401.
158. McGeehan, G. M.; Becherer, J. D.; Bast, R. C., Jr.; Boyer, C. M.; Champion, B.; Connolly, K. M.; Conway, J. G.; Furdon, P.; Karp, S.; Kidao, S. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 1994, 370 (6490), 558-61. (Pubitemid 24264921)
159. Gearing, A. J.; Beckett, P.; Christodoulou, M.; Churchill, M.; Clements, J.; Davidson, A. H.; Drummond, A. H.; Galloway, W. A.; Gilbert, R.; Gordon, J. L. Processing of tumour necrosis factoralpha precursor by metalloproteinases. Nature 1994, 370 (6490), 555-7. (Pubitemid 24264920)
160. Tellier, E.; Canault, M.; Rebsomen, L.; Bonardo, B.; Juhan-Vague, I.; Nalbone, G.; Peiretti, F. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp. Cell Res. 2006, 312 (20), 3969-80. (Pubitemid 44828045)
161. Tellier, E.; Canault, M.; Poggi, M.; Bonardo, B.; Nicolay, A.; Alessi, M. C.; Nalbone, G.; Peiretti, F. HDLs activate ADAM17-dependent shedding. J. Cell Physiol. 2008, 214 (3), 687-93. (Pubitemid 351224213)
162. Amour, A.; Slocombe, P. M.; Webster, A.; Butler, M.; Knight, C. G.; Smith, B. J.; Stephens, P. E.; Shelley, C.; Hutton, M.; Knauper, V.; Docherty, A. J.; Murphy, G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 1998, 435 (1), 39-44. (Pubitemid 28432011)
163. Gelling, R. W.; Yan, W.; Al Noori, S.; Pardini, A.; Morton, G. J.; Ogimoto, K.; Schwartz, M. W.; Dempsey, P. J. Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology 2008, 149 (12), 6053-64.
164. Peschon, J. J.; Slack, J. L.; Reddy, P.; Stocking, K. L.; Sunnarborg, S. W.; Lee, D. C.; Russell, W. E.; Castner, B. J.; Johnson, R. S.; Fitzner, J. N.; Boyce, R. W.; Nelson, N.; Kozlosky, C. J.; Wolfson, M. F.; Rauch, C. T.; Cerretti, D. P.; Paxton, R. J.; March, C. J.; Black, R. A. An essential role for ectodomain shedding in mammalian development. Science 1998, 282 (5392), 1281-4. (Pubitemid 28524483)
165. Maskos, K.; Fernandez-Catalan, C.; Huber, R.; Bourenkov, G. P.; Bartunik, H.; Ellestad, G. A.; Reddy, P.; Wolfson, M. F.; Rauch, C. T.; Castner, B. J.; Davis, R.; Clarke, H. R.; Petersen, M.; Fitzner, J. N.; Cerretti, D. P.; March, C. J.; Paxton, R. J.; Black, R. A.; Bode, W. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (7), 3408-12. (Pubitemid 28173141)
166. Reddy, P.; Slack, J. L.; Davis, R.; Cerretti, D. P.; Kozlosky, C. J.; Blanton, R. A.; Shows, D.; Peschon, J. J.; Black, R. A. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 2000, 275 (19), 14608-14. (Pubitemid 30339751)
167. Doedens, J. R.; Black, R. A. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 2000, 275 (19), 14598-607. (Pubitemid 30339750)
168. Hino, T.; Nakamura, H.; Abe, S.; Saito, H.; Inage, M.; Terashita, K.; Kato, S.; Tomoike, H. Hydrogen peroxide enhances shedding of type I soluble tumor necrosis factor receptor from pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 1999, 20 (1), 122-8. (Pubitemid 129504850)
169. Schaff, U.; Mattila, P. E.; Simon, S. I.; Walcheck, B. Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM17 and its proteolytic substrate L-selectin. J. Leukoc. Biol. 2008, 83 (1), 99-105.
170. Wang, Y.; Zhang, A. C.; Ni, Z.; Herrera, A.; Walcheck, B. ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. J. Immunol. 2010, 184 (8), 4447-54.
171. Buxbaum, J. D.; Liu, K. N.; Luo, Y.; Slack, J. L.; Stocking, K. L.; Peschon, J. J.; Johnson, R. S.; Castner, B. J.; Cerretti, D. P.; Black, R. A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 1998, 273 (43), 27765-7. (Pubitemid 28496060)
172. Fisher, A. M1 muscarinic agonists target major hallmarks of Alzheimer's disease-the pivotal role of brain M1 receptors. Neurodegener. Dis. 2008, 5 (3-4), 237-40. (Pubitemid 351347860)
173. Alfa, C. M.; Sunyach, C.; Slack, B. E.; Fisher, A.; Vincent, B.; Checler, F. M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J. Neurosci. 2007, 27 (15), 4083-92. (Pubitemid 46597172)
174. Jackson, L. F.; Qiu, T. H.; Sunnarborg, S. W.; Chang, A.; Zhang, C.; Patterson, C.; Lee, D. C. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 2003, 22 (11), 2704-16. (Pubitemid 36712367)
175. Lee, D. C.; Sunnarborg, S. W.; Hinkle, C. L.; Myers, T. J.; Stevenson, M. Y.; Russell, W. E.; Castner, B. J.; Gerhart, M. J.; Paxton, R. J.; Black, R. A.; Chang, A.; Jackson, L. F. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. N.Y. Acad. Sci. 2003, 995, 22-38. (Pubitemid 36706611)
176. Shao, M. X.; Ueki, I. F.; Nadel, J. A. Tumor necrosis factor alphaconverting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (20), 11618-23. (Pubitemid 37205985)
177. Shao, M. X.; Nakanaga, T.; Nadel, J. A. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alphaconverting enzyme in human airway epithelial (NCI-H292) cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 287 (2), L420-L427. (Pubitemid 38943925)
178. Shao, M. X.; Nadel, J. A. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (3), 767-72. (Pubitemid 40282740)
179. Shao, M. X.; Nadel, J. A. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNFalpha- converting enzyme. J. Immunol. 2005, 175 (6), 4009-16.
180. Horiuchi, K.; Kimura, T.; Miyamoto, T.; Takaishi, H.; Okada, Y.; Toyama, Y.; Blobel, C. P. Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 2007, 179 (5), 2686-9.
181. Canault, M.; Leroyer, A. S.; Peiretti, F.; Leseche, G.; Tedgui, A.; Bonardo, B.; Alessi, M. C.; Boulanger, C. M.; Nalbone, G. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am. J. Pathol. 2007, 171 (5), 1713-23. (Pubitemid 350158331)
182. Mochizuki, S.; Okada, Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98 (5), 621-8. (Pubitemid 46563436)
183. Kenny, P. A.; Bissell, M. J. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest 2007, 117 (2), 337-45. (Pubitemid 46203962)
184. Franovic, A.; Robert, I.; Smith, K.; Kurban, G.; Pause, A.; Gunaratnam, L.; Lee, S. Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17. Cancer Res. 2006, 66 (16), 8083-90. (Pubitemid 44299174)
185. Waldhauer, I.; Goehlsdorf, D.; Gieseke, F.; Weinschenk, T.; Wittenbrink, M.; Ludwig, A.; Stevanovic, S.; Rammensee, H. G.; Steinle, A. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 2008, 68 (15), 6368-76.
186. Boutet, P.; Aguera-Gonzalez, S.; Atkinson, S.; Pennington, C. J.; Edwards, D. R.; Murphy, G.; Reyburn, H. T.; Vales-Gomez, M. Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J. Immunol. 2009, 182 (1), 49-53.
187. Fritsche, J.; Moser, M.; Faust, S.; Peuker, A.; Buttner, R.; Andreesen, R.; Kreutz, M. Molecular cloning and characterization of a human metalloprotease disintegrin-a novel marker for dendritic cell differentiation. Blood 2000, 96 (2), 732-9. (Pubitemid 30463399)
188. Inoue, D.; Reid, M.; Lum, L.; Kratzschmar, J.; Weskamp, G.; Myung, Y. M.; Baron, R.; Blobel, C. P. Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells. J. Biol. Chem. 1998, 273 (7), 4180-7. (Pubitemid 28103288)
189. Kurisaki, T.; Masuda, A.; Osumi, N.; Nabeshima, Y.; Fujisawa- Sehara, A. Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo. Mech. Dev. 1998, 73 (2), 211-5. (Pubitemid 28281398)
190. Zhou, H. M.; Weskamp, G.; Chesneau, V.; Sahin, U.; Vortkamp, A.; Horiuchi, K.; Chiusaroli, R.; Hahn, R.; Wilkes, D.; Fisher, P.; Baron, R.; Manova, K.; Basson, C. T.; Hempstead, B.; Blobel, C. P. Essential role for ADAM19 in cardiovascular morphogenesis. Mol. Cell. Biol. 2004, 24 (1), 96-104. (Pubitemid 38010038)
191. Kurisaki, T.; Wakatsuki, S.; Sehara-Fujisawa, A. Meltrin beta mini, a new ADAM19 isoform lacking metalloprotease and disintegrin domains, induces morphological changes in neuronal cells. FEBS Lett. 2002, 532 (3), 419-22. (Pubitemid 35441385)
192. Kang, T.; Zhao, Y. G.; Pei, D.; Sucic, J. F.; Sang, Q. X. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J. Biol. Chem. 2002, 277 (28), 25583-91. (Pubitemid 34951875)
193. Kang, T.; Park, H. I.; Suh, Y.; Zhao, Y. G.; Tschesche, H.; Sang, Q. X. Autolytic processing at Glu586-Ser587 within the cysteinerich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. J. Biol. Chem. 2002, 277 (50), 48514-48512. (Pubitemid 35470812)
194. Wei, P.; Zhao, Y. G.; Zhuang, L.; Ruben, S.; Sang, Q. X. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. Biochem. Biophys. Res. Commun. 2001, 280 (3), 744-755. (Pubitemid 32924493)
195. Chesneau, V.; Becherer, J. D.; Zheng, Y.; Erdjument-Bromage, H.; Tempst, P.; Blobel, C. P. Catalytic properties of ADAM19. J. Biol. Chem. 2003, 278 (25), 22331-22340. (Pubitemid 36830282)
196. Wong, B. R.; Josien, R.; Lee, S. Y.; Sauter, B.; Li, H. L.; Steinman, R. M.; Choi, Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997, 186 (12), 2075-80. (Pubitemid 28013694)
197. Shirakabe, K.; Wakatsuki, S.; Kurisaki, T.; Fujisawa-Sehara, A. Roles of Meltrin beta /ADAM19 in the processing of neuregulin. J. Biol. Chem. 2001, 276 (12), 9352-8.
198. Wakatsuki, S.; Kurisaki, T.; Sehara-Fujisawa, A. Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin beta/ADAM19. J. Neurochem. 2004, 89 (1), 119-23. (Pubitemid 38420680)
199. Yokozeki, T.; Wakatsuki, S.; Hatsuzawa, K.; Black, R. A.; Wada, I.; Sehara-Fujisawa, A. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlationspectroscopicobservationofthedynamicsofectodomain shedding in living cells. Genes Cells 2007, 12 (3), 329-43. (Pubitemid 46359587)
200. Horiuchi, K.; Zhou, H. M.; Kelly, K.; Manova, K.; Blobel, C. P. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev. Biol. 2005, 283 (2), 459-71. (Pubitemid 40977963)
201. Tanabe, C.; Hotoda, N.; Sasagawa, N.; Sehara-Fujisawa, A.; Maruyama, K.; Ishiura, S. ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells. Biochem. Biophys. Res. Commun. 2007, 352 (1), 111-7. (Pubitemid 44821101)
202. Melenhorst, W. B.; van den Heuvel, M. C.; Stegeman, C. A.; van der, L. J.; Huitema, S.; van den, B. A.; van Goor, H. Upregulation of ADAM19 in chronic allograft nephropathy. Am. J. Transplant. 2006, 6 (7), 1673-81. (Pubitemid 43945809)
203. Melenhorst, W. B.; van den Heuvel, M. C.; Timmer, A.; Huitema, S.; Bulthuis, M.; Timens, W.; van Goor, H. ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration. Kidney Int. 2006, 70 (7), 1269-78. (Pubitemid 44435178)
204. Hooft van Huijsduijnen, R. ADAM 20 and 21; two novel human testis-specific membrane metalloproteases with similarity to fertilin-alpha. Gene 1998, 206 (2), 273-82. (Pubitemid 28083284)
205. Cerretti, D. P.; DuBose, R. F.; Black, R. A.; Nelson, N. Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression. Biochem. Biophys. Res. Commun. 1999, 263 (3), 810-5. (Pubitemid 29490709)
206. Jury, J. A.; Perry, A. C.; Hall, L. Identification, sequence analysis and expression of transcripts encoding a putative metalloproteinase, eMDC II, in human and macaque epididymis. Mol. Hum. Reprod. 1999, 5 (12), 1127-34.
207. Roberts, C. M.; Tani, P. H.; Bridges, L. C.; Laszik, Z.; Bowditch, R. D. MDC-L, a novel metalloprotease disintegrin cysteine-rich protein family member expressed by human lymphocytes. J. Biol. Chem. 1999, 274 (41), 29251-9.
208. Sagane, K.; Ohya, Y.; Hasegawa, Y.; Tanaka, I. Metalloproteinaselike, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain. Biochem. J. 1998, 334 (Pt 1), 93-8. (Pubitemid 28420976)
209. Mochizuki, S.; Shimoda, M.; Shiomi, T.; Fujii, Y.; Okada, Y. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem. Biophys. Res. Commun. 2004, 315 (1), 79-84. (Pubitemid 38175188)
210. Howard, L.; Zheng, Y.; Horrocks, M.; Maciewicz, R. A.; Blobel, C. Catalytic activity of ADAM28. FEBS Lett. 2001, 498 (1), 82-6. (Pubitemid 32522896)
211. Bridges, L. C.; Tani, P. H.; Hanson, K. R.; Roberts, C. M.; Judkins, M. B.; Bowditch, R. D. The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1. J. Biol. Chem. 2002, 277 (5), 3784-92. (Pubitemid 34953253)
212. Bridges, L. C.; Hanson, K. R.; Tani, P. H.; Mather, T.; Bowditch, R. D. Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domain. Biochemistry 2003, 42 (13), 3734-41. (Pubitemid 36402666)
213. Oh, J.; Woo, J. M.; Choi, E.; Kim, T.; Cho, B. N.; Park, Z. Y.; Kim, Y. C.; Kim, D. H.; Cho, C. Molecular, biochemical, and cellular characterization of epididymal ADAMs, ADAM7 and ADAM28. Biochem. Biophys. Res. Commun. 2005, 331 (4), 1374-83. (Pubitemid 40692508)
214. Zhao, Z.; Wen, L. Y.; Jin, M.; Deng, Z. H.; Jin, Y. ADAM28 participates in the regulation of tooth development. Arch. Oral Biol. 2006, 51 (11), 996-1005. (Pubitemid 44442103)
215. Zhao, Z.; Tang, L.; Deng, Z.; Wen, L.; Jin, Y. Essential role of ADAM28 in regulating the proliferation and differentiation of human dental papilla mesenchymal cells (hDPMCs). Histochem. Cell Biol. 2008, 130 (5), 1015-1025.
216. Zhao, Z.; Liu, H.; Jin, Y.; Lingling, E. Influence of ADAM28 on biological characteristics of human dental follicle cells. Arch. Oral Biol. 2009, 54 (9), 835-45.
217. Ohtsuka, T.; Shiomi, T.; Shimoda, M.; Kodama, T.; Amour, A.; Murphy, G.; Ohuchi, E.; Kobayashi, K.; Okada, Y. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis. Int. J. Cancer 2006, 118 (2), 263-73. (Pubitemid 41779063)
218. Kuroda, H.; Mochizuki, S.; Shimoda, M.; Chijiiwa, M.; Kamiya, K.; Izumi, Y.; Watanabe, M.; Horinouchi, H.; Kawamura, M.; Kobayashi, K.; Okada, Y. ADAM28 is a serological and histochemical marker for non-small-cell lung cancers. Int. J. Cancer 2010, 127 (8), 1844-1856.
219. Mitsui, Y.; Mochizuki, S.; Kodama, T.; Shimoda, M.; Ohtsuka, T.; Shiomi, T.; Chijiiwa, M.; Ikeda, T.; Kitajima, M.; Okada, Y. ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulinlike growth factor binding protein-3. Cancer Res. 2006, 66 (20), 9913-20. (Pubitemid 44672043)
220. Yoshinaka, T.; Nishii, K.; Yamada, K.; Sawada, H.; Nishiwaki, E.; Smith, K.; Yoshino, K.; Ishiguro, H.; Higashiyama, S. Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity. Gene 2002, 282 (1-2), 227-36. (Pubitemid 34117579)
221. Van Eerdewegh, P.; Little, R. D.; Dupuis, J.; Del Mastro, R. G.; Falls, K.; Simon, J.; Torrey, D.; Pandit, S.; McKenny, J.; Braunschweiger, K.; Walsh, A.; Liu, Z.; Hayward, B.; Folz, C.; Manning, S. P.; Bawa, A.; Saracino, L.; Thackston, M.; Benchekroun, Y.; Capparell, N.; Wang, M.; Adair, R.; Feng, Y.; Dubois, J.; FitzGerald, M. G.; Huang, H.; Gibson, R.; Allen, K. M.; Pedan, A.; Danzig, M. R.; Umland, S. P.; Egan, R. W.; Cuss, F. M.; Rorke, S.; Clough, J. B.; Holloway, J. W.; Holgate, S. T.; Keith, T. P. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418 (6896), 426-30. (Pubitemid 34826843)
222. Garlisi, C. G.; Zou, J.; Devito, K. E.; Tian, F.; Zhu, F. X.; Liu, J.; Shah, H.; Wan, Y.; Motasim, B. M.; Egan, R. W.; Umland, S. P. Human ADAM33: Protein maturation and localization. Biochem. Biophys. Res. Commun. 2003, 301 (1), 35-43. (Pubitemid 36268844)
223. Bridges, L. C.; Sheppard, D.; Bowditch, R. D. ADAM disintegrinlike domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7. Biochem. J. 2005, 387 (Pt 1), 101-8. (Pubitemid 40524079)
224. Huang, J.; Bridges, L. C.; White, J. M. Selective modulation of integrin-mediated cell migration by distinct ADAM family members. Mol. Biol. Cell 2005, 16 (10), 4982-91. (Pubitemid 41416475)
225. Zou, J.; Zhu, F.; Liu, J.; Wang, W.; Zhang, R.; Garlisi, C. G.; Liu, Y. H.; Wang, S.; Shah, H.; Wan, Y.; Umland, S. P. Catalytic activity of human ADAM33. J. Biol. Chem. 2004, 279 (11), 9818-30. (Pubitemid 38372580)
226. Orth, P.; Reichert, P.; Wang, W.; Prosise, W. W.; Yarosh-Tomaine, T.; Hammond, G.; Ingram, R. N.; Xiao, L.; Mirza, U. A.; Zou, J.; Strickland, C.; Taremi, S. S.; Le, H. V.; Madison, V. Crystal structure of the catalytic domain of human ADAM33. J. Mol. Biol. 2004, 335 (1), 129-37. (Pubitemid 37494967)
227. Yang, Y.; Haitchi, H. M.; Cakebread, J.; Sammut, D.; Harvey, A. Powell RM, Holloway JW, Howarth P, Holgate ST, Davies DE: Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells. J. Allergy Clin. Immunol. 2008, 121 (6), 13939-13999.
228. Umland, S. P.; Garlisi, C. G.; Shah, H.; Wan, Y.; Zou, J.; Devito, K. E.; Huang, W. M.; Gustafson, E. L.; Ralston, R. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am. J. Respir. Cell Mol. Biol. 2003, 29 (5), 571-82. (Pubitemid 37357708)
229. Powell, R. M.; Wicks, J.; Holloway, J. W.; Holgate, S. T.; Davies, D. E. The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am. J. Respir. Cell Mol. Biol. 2004, 31 (1), 13-21. (Pubitemid 38888034)
230. Haitchi, H. M.; Powell, R. M.; Shaw, T. J.; Howarth, P. H.; Wilson, S. J.; Wilson, D. I.; Holgate, S. T.; Davies, D. E. ADAM33 expression in asthmatic airways and human embryonic lungs. Am. J. Respir. Crit. Care Med. 2005, 171 (9), 958-65. (Pubitemid 40616943)
231. Umland, S. P.; Wan, Y.; Shah, H.; Garlisi, C. G.; Devito, K. E.; Braunschweiger, K.; Gheyas, F.; Del Mastro, R. Mouse ADAM33: two splice variants differ in protein maturation and localization. Am. J. Respir. Cell Mol. Biol. 2004, 30 (4), 530-9. (Pubitemid 38460965)
232. Puxeddu, I.; Pang, Y. Y.; Harvey, A.; Haitchi, H. M.; Nicholas, B.; Yoshisue, H.; Ribatti, D.; Clough, G.; Powell, R. M.; Murphy, G.; Hanley, N. A.; Wilson, D. I.; Howarth, P. H.; Holgate, S. T.; Davies, D. E. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J. Allergy Clin. Immunol. 2008, 121 (6), 14006, 1406.
233. Lee, J. Y.; Park, S. W.; Chang, H. K.; Kim, H. Y.; Rhim, T.; Lee, J. H.; Jang, A. S.; Koh, E. S.; Park, C. S. A disintegrin and metalloproteinase 33 protein in patients with asthma: Relevance to airflow limitation. Am. J. Respir. Crit. Care Med. 2006, 173 (7), 729-35.
234. Ito, I.; Laporte, J. D.; Fiset, P. O.; Asai, K.; Yamauchi, Y.; Martin, J. G.; Hamid, Q. Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells. J. Allergy Clin. Immunol. 2007, 119 (1), 89-97. (Pubitemid 46037804)
235. Chen, C.; Huang, X.; Sheppard, D. ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol. Cell. Biol. 2006, 26 (18), 6950-6. (Pubitemid 44387643)
236. Howard, T. D.; Postma, D. S.; Jongepier, H.; Moore, W. C.; Koppelman, G. H.; Zheng, S. L.; Xu, J.; Bleecker, E. R.; Meyers, D. A. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 2003, 112 (4), 717-22. (Pubitemid 37260387)
237. Kedda, M. A.; Duffy, D. L.; Bradley, B.; O'Hehir, R. E.; Thompson, P. J. ADAM33 haplotypes are associated with asthma in a large Australian population. Eur. J. Hum. Genet. 2006, 14 (9), 1027-36. (Pubitemid 44275836)
238. van Diemen, C. C.; Postma, D. S.; Vonk, J. M.; Bruinenberg, M.; Schouten, J. P.; Boezen, H. M. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am. J. Respir. Crit. Care Med. 2005, 172 (3), 329-33. (Pubitemid 41026143)
239. Lind, D. L.; Choudhry, S.; Ung, N.; Ziv, E.; Avila, P. C.; Salari, K.; Ha, C.; Lovins, E. G.; Coyle, N. E.; Nazario, S.; Casal, J.; Torres, A.; Rodriguez-Santana, J. R.; Matallana, H.; Lilly, C. M.; Salas, J.; Selman, M.; Boushey, H. A.; Weiss, S. T.; Chapela, R.; Ford, J. G.; Rodriguez-Cintron, W.; Silverman, E. K.; Sheppard, D.; Kwok, P. Y.; Gonzalez, B. E. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am. J. Respir. Crit. Care Med. 2003, 168 (11), 1312-6. (Pubitemid 37487325)
240. Wang, P.; Liu, Q. J.; Li, J. S.; Li, H. C.; Wei, C. H.; Guo, C. H.; Gong, Y. Q. Lack of association between ADAM33 gene and asthma in a Chinese population. Int. J. Immunogenet. 2006, 33 (4), 303-6. (Pubitemid 44086973)
241. Reijmerink, N. E.; Kerkhof, M.; Koppelman, G. H.; Gerritsen, J.; de Jongste, J. C.; Smit, H. A.; Brunekreef, B.; Postma, D. S. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness. Allergy 2009, 64 (6), 898-904.
242. Holgate, S. T.; Yang, Y.; Haitchi, H. M.; Powell, R. M.; Holloway, J. W.; Yoshisue, H.; Pang, Y. Y.; Cakebread, J.; Davies, D. E. The genetics of asthma: ADAM33 as an example of a susceptibility gene. Proc. Am. Thorac. Soc. 2006, 3 (5), 440-3. (Pubitemid 44033360)
243. Saglani, S.; Bush, A. The early-life origins of asthma. Curr. Opin. Allergy Clin. Immunol. 2007, 7 (1), 83-90. (Pubitemid 46095891)
244. Holloway, J. W.; Yang, I. A.; Holgate, S. T. Genetics of allergic disease. J. Allergy Clin. Immunol. 2010, 125 (2 Suppl 2), S81-S94.
245. Gosman, M. M.; Boezen, H. M.; van Diemen, C. C.; Snoeck- Stroband, J. B.; Lapperre, T. S.; Hiemstra, P. S.; Ten Hacken, N. H.; Stolk, J.; Postma, D. S. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007, 62 (3), 242-7. (Pubitemid 46579805)
246. Lesueur, F.; Oudot, T.; Heath, S.; Foglio, M.; Lathrop, M.; Prud'homme, J. F.; Fischer, J. ADAM33, a new candidate for psoriasis susceptibility. PLoS ONE 2007, 2 (9), e906.
247. Siroux, V.; Bouzigon, E.; Dizier, M. H.; Pin, I.; Demenais, F.;
248. Deng, W.; Liang, W. B.; Gao, L. B.; Wang, Y. Y.; Lv, M. L.; Zhu, Y.; Zhang, L. Association of ADAM33 Polymorphisms and Susceptibility to Psoriasis. DNA Cell Biol. 2010, doi:10.1089/dna.2009.1002.
249. Beck, V.; Herold, H.; Benge, A.; Luber, B.; Hutzler, P.; Tschesche, H.; Kessler, H.; Schmitt, M.; Geppert, H. G.; Reuning, U. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. Int. J. Biochem. Cell Biol. 2005, 37 (3), 590-603. (Pubitemid 40022936)